Top Industry Leaders in the Glioma Diagnosis Treatment Market
Latest Glioma Diagnosis and Treatment Companies Updates:
Roche receives FDA approval for its Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for treating recurrent glioblastoma, offering a new treatment option for advanced Glioma patients.
Merck KGaA announces positive preliminary data from a Phase 2b clinical trial of its investigational drug Xpozio® (selinexor) in combination with temozolomide for treating newly diagnosed high-grade Glioma, showing promising response rates.
Optune® from Novocure expands its reach with the FDA approval for treating adult low-grade glioma (LGG), offering a non-invasive treatment option for LGG patients.
The National Brain Tumor Society (NBTS) partners with research institutions and pharmaceutical companies to advance Glioma research and accelerate development of new treatment options.
List of Glioma Diagnosis and Treatment Key companies in the market:
- Thermo Fisher Scientific Inc.
- Emcure Pharmaceuticals Ltd.
- Sigma-Aldrich Co.
- Pfizer Inc.
- Taj Pharmaceuticals Limited
- Novartis International AG
- Teva Pharmaceutical Industries Ltd.
- GE Healthcare
- Siemens Healthineers
- Philips Healthcare
- Shimadzu Corporation
